Adam Dubow's Net Worth
$2.27 Million
Who is Adam Dubow?
Adam Dubow has an estimated net worth of $2.27 Million. This is based on reported shares across multiple companies, which include BRISTOL MYERS SQUIBB CO, and Day One Biopharmaceuticals, Inc..
SEC CIK
Adam Dubow's CIK is 0001744507
Past Insider Trading and Trends
2021 was Adam Dubow's most active year for acquiring shares with 11 total transactions. Adam Dubow's most active month to acquire stocks was the month of February. 2019 was Adam Dubow's most active year for disposing of shares, totalling 15 transactions. Adam Dubow's most active month to dispose stocks was the month of February. 2024 saw Adam Dubow paying a total of $0.00 for 174,197 shares, this is the most they've acquired in one year. In 2021 Adam Dubow cashed out on 12,935 shares for a total of $484,088.69, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BRISTOL MYERS SQUIBB CO (BMY) Snapshot price: $48.6
SVP,ChiefCompliance&EthicsOff.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -15.18% | -2.47K |
$67.90 | -$167,441.40 | 13.78K |
Jul 30
| |||
Form 4
| -16.11% | -3.12K |
$64.21 | -$200,270.99 | 16.24K |
May 5
| |||
Form 4
| +27.50% | 4.18K |
$60.93 | -$116,376.30 | 19.36K |
Mar 10
| |||
Form 4
| -5.59% | -900.00 |
$63.39 | -$57,051.00 | 15.19K |
Nov 24
| |||
Form 4
| -16.59% | -3.20K |
$61.01 | -$195,232.00 | 16.09K |
May 22
| |||
Form 4
| +22.46% | 3.54K |
$57.93 | -$116,149.65 | 19.29K |
Mar 10
| |||
Form 4
| -9.95% | -1.74K |
$58.81 | -$102,329.40 | 15.75K |
Dec 5
| |||
Form 4
| +14.89% | 2.27K |
$51.39 | -$60,742.98 | 17.49K |
Mar 10
| |||
Form 4
| +3.57% | 524 |
$60.55 | -$16,530.15 | 15.22K |
Sep 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Day One Biopharmaceuticals, Inc. (DAWN) Snapshot price: $13.5
GENERAL COUNSEL
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +23.92% | 5.2K |
$14.00 | -$44,825.12 | 26.93K |
Aug 15 - Aug 16
| |||
Form 4
| +31.03% | 5.15K |
$16.08 | -$52,304.01 | 21.73K |
May 15 - May 16
| |||
Form 4
| +45.13% | 5.16K |
$15.25 | -$49,434.34 | 16.59K |
Feb 15 - Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
| +263.83% | 8.29K |
$11.69 | -$62,108.97 | 11.43K |
Nov 15 - Nov 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||